Long-Term Antithyroid Drug Treatment of Graves’ Disease in Children and Adolescents: A 20-Year Single-Center Experience
Background/purposeGraves’ disease (GD) is the most common cause of thyrotoxicosis in children and adolescents. There is some debate regarding the optimal treatment and predicting factors of remission or relapse in children and adolescents with GD. In this study, we report a retrospective study of 19...
Main Authors: | Ari Song, Su Jin Kim, Min-Sun Kim, Jiyeon Kim, Insung Kim, Ga Young Bae, Eunseop Seo, Young Seok Cho, Joon Young Choi, Sung Yoon Cho, Dong-Kyu Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2021.687834/full |
Similar Items
-
Predictive Value of Gene Polymorphisms on Recurrence after the Withdrawal of Antithyroid Drugs in Patients with Graves’ Disease
by: Jia Liu, et al.
Published: (2017-09-01) -
The treatment of Graves' disease in children and adolescents
by: Hae Sang Lee, et al.
Published: (2014-09-01) -
Total thyroidectomy (Tx) versus thionamides (antithyroid drugs) in patients with moderate-to-severe Graves’ ophthalmopathy – a 1-year follow-up: study protocol for a randomized controlled trial
by: Lindsay Brammen, et al.
Published: (2018-09-01) -
Graves' Disease: Can It Be Cured?
by: Wilmar M. Wiersinga
Published: (2019-03-01) -
Antithyroid drugs and birth defects
by: Stine Linding Andersen, et al.
Published: (2020-06-01)